Bio­haven shakes up lead­er­ship team as it feels the heat from mi­graine com­peti­tors

As Bio­haven Phar­ma comes off a roller­coast­er pipeline year, its CEO will take on more re­spon­si­bil­i­ty in a full C-suite makeover.

Vlad Coric was unan­i­mous­ly elect­ed to the role of chair­man of the board of di­rec­tors, af­ter De­clan Doogan’s re­tire­ment. Matthew Buten will take over the role of CFO af­ter James En­gel­hart’s re­tire­ment, and di­rec­tor Michael Hef­fer­nan has been ap­point­ed lead in­de­pen­dent di­rec­tor. All of the ap­point­ments are ef­fec­tive im­me­di­ate­ly, a com­pa­ny press re­lease said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER